Dr. Reddy's API Manufacturing Capabilities:
Dr. Reddy’s manufactures 250+ APIs across India, Mexico, and the UK, with eight USFDA-inspected cGMP facilities—six in India, one in Mexico, and one in the UK. All facilities comply with ICH Q7 guidelines and are regularly audited by global regulatory authorities including USFDA, EMA, ANVISA, PMDA, Health Canada, and others.
With 40+ years of technical leadership, we specialize in complex APIs such as steroids, peptides, long-chain molecules, and HPAPIs. Our R&D teams develop robust, scalable processes and support customers through dossier filings and commercialization worldwide.
Dr. Reddy’s API division is strategically working towards becoming the number one API company in the world by focusing on strong innovation, global footprint, and exceptional customer service. As one of the top API manufacturers in USA driven by consistency and the increasing need for good health, we are committed to improving access to our APIs across the United States.
Reliable, Sustainable Supply Chain
- Multi-sourced KSMs for supply resilience
- Stringent quality specifications and timely deliveries
- Capacity expansion to meet global demand for essential APIs
Dr. Reddy’s combines deep scientific expertise, global compliance, and sustainable manufacturing to be your trusted API partner.
40+ Years of Expertise
Leading supplier of APIs for more than 40 years, with an industry leading portfolio of generic APIs and partner of choice for global formulators.
8 Manufacturing units
We have 8 commercial USFDA inspected API plants/production units, of which 6 are in India and 1 in Uk and 1 in Mexico.
Manufacturing Capacity
Sufficient manufacturing capacity and flexible batch sizes enable fast turnaround times, supported by backward integration and a resilient supply chain to ensure consistent, uninterrupted delivery.
Safety and Compliance
All our plants are operated in accordance with cGMP (ICH Q7a) and are regularly inspected/audited by international authorities and agencies.
Manufacturing Locations
- Mirfield, UK
- Cuernavaca, Mexico
- CTO VI Vizag & CTO-SEZ Vizag
- CTO - I, II, III, Hyderabad
- CTO - V (Miryalaguda, Nalgonda)
国別の要件がある場合は、お手伝いいたします。
Manufacturing Capabilities
- 250+ APIs
- 4,100+ KL of reactor volumes.
- 1250+ Reactors including ~100+ reactors with containment across 4 sites (HPAI /Oncology/ steroids/prostaglandins).
- 5,000+ MT of Intermediates manufactured.
- 90% of our API pipeline is forward integrated to generic formulations.
- 100+ Commercial Molecules
- 50+ Pipeline molecules (Filed + under development).
- 2,100+ MT of APIs manufactured.
- Deep expertise in handing complex peptide molecules.
- Can handle molecules of OEL up to 0.1 µg/m3 by protecting environment, people & product.
Quality Control
Quality Control Policies
A key component in quality control in pharmaceutical industry is helping customers by providing a quality product. We achieve this by ensuring that all our facilities operate efficiently and to the latest quality, safety, and productivity standards.
At Dr. Reddy’s, quality control is central to our commitment to delivering safe, high-quality APIs. Our facilities operate under cGMP (ICH Q7) standards, ensuring global regulatory compliance and consistent product performance.
Advanced Analytical & Process Excellence
- Scalable manufacturing for consistent quality
- Robust analytical methods to eliminate nitrosamine and azido impurities
- Comprehensive impurity profiling, characterization, and control
- Use of advanced techniques to define chemical and physical attributes
- Efficient operations aligned with the latest quality, safety, and productivity standards
Quality Assurance
The pharmaceutical quality assurance (QA) team at Dr. Reddy’s continually monitors various facets of the quality management system. We are committed to maintaining highest quality standards in cGMP manufacturing through periodic reviews and continuous improvement of quality management system. All our manufacturing units have undergone multiple cGMP audits by various regulatory authorities, and numerous quality audits by various customers. As a result, our high-quality APIs meets all the formulation needs for various global markets.
Review Meetings for Quality Control
Dr. Reddy’s maintains a robust quality system through continuous monitoring, cross-functional audits, and harmonized procedures across all API manufacturing units. Every facility operates under cGMP (ICH Q7) and is regularly inspected by global regulatory authorities.
Recognized for our strong compliance record, we support customers with:
- DMF, CMC, IND, and NDA filings
- Deep experience with USFDA, EMA, WHO GMP, PMDA, KFDA, ANVISA, Health Canada, and more
Related Pages
R & D
Customer Service
Regulatory
免責事項
このウェブサイト上のいかなる情報も、製品またはサービスへの言及を含め、販売の申し出を構成するものではなく、販売の申し出を表すものと解釈されるものでもありません。有効な特許により保護されている製品は、商用目的で提供または提供されるものではありません。ただし、特定のケースでは、Dr. Reddy の独自の裁量により、現地の法的要件に従って、そのような製品の研究用数量が、規制免除が存在する場所に、インド特許法第 107A 条 (Bolar 免除) に基づく規制提出の目的で提供される場合があります。購入者は、それぞれの市場における特許シナリオを含む製品またはサービスについて独自の評価を行う必要があり、すべての特許関連法的責任を負うことになります。Dr. Reddy は、商品性、特定目的への適合性、および非侵害の保証を含むがこれらに限定されない、明示または黙示を問わずすべての保証を否認します。